El-Sahwi, K <br/><br/>
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.  [electronic resource] 

 -  British journal of cancer  Jan 2010 
 - 134-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605448  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Papillary--pathology<br/>Aged<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antibody-Dependent Cell Cytotoxicity--drug effects<br/>Cell Line, Tumor--drug effects<br/>Complement System Proteins--immunology<br/>Cytotoxicity, Immunologic<br/>Dimerization<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Female<br/>Humans<br/>Immunoglobulin G--immunology<br/>In Vitro Techniques<br/>Interleukin-2--pharmacology<br/>Killer Cells, Natural--immunology<br/>Lymphocytes--immunology<br/>Middle Aged<br/>Receptor, ErbB-2--biosynthesis<br/>Signal Transduction--drug effects<br/>Trastuzumab<br/>Uterine Neoplasms--pathology